Multiple sclerosis and Keratosis pilaris

Summary:

Keratosis pilaris is found among people with Multiple sclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Keratosis pilaris with Multiple sclerosis. It is created by eHealthMe based on reports of 28 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Keratosis pilaris?

Keratosis pilaris (a condition in which there are numerous rough follicular spots, which may be skin coloured, red or brown) is found to be associated with 34 drugs and 247 conditions by eHealthMe. Check the latest studies of Keratosis pilaris.



On Jul, 09, 2026

28 people who have Multiple Sclerosis and Keratosis Pilaris are studied.

Would you have Keratosis pilaris when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Keratosis Pilaris *:

  • female: 57.14 %
  • male: 42.86 %

Age of people who have Multiple Sclerosis and experienced Keratosis Pilaris *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 4 %
  • 30-39: 32 %
  • 40-49: 28 %
  • 50-59: 36 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 10.71%
  2. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 7.14%
  3. Eye Disorder: 2 people, 7.14%
  4. Upper-Airway Cough Syndrome: 1 person, 3.57%
  5. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 3.57%
  6. Hypersensitivity: 1 person, 3.57%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 3.57%
  8. Depression: 1 person, 3.57%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 3.57%
  10. Birth Control: 1 person, 3.57%

Common drugs taken by these people *:

  1. Gilenya: 18 people, 64.29%
  2. Tysabri: 4 people, 14.29%
  3. Avonex: 2 people, 7.14%
  4. Tecfidera: 2 people, 7.14%
  5. Solu-Medrol: 2 people, 7.14%
  6. Ocrevus: 2 people, 7.14%
  7. Plegridy: 2 people, 7.14%
  8. Copaxone: 1 person, 3.57%
  9. Dilaudid: 1 person, 3.57%
  10. Depo-Provera: 1 person, 3.57%

Common symptoms for these people *:

  1. Alanine Aminotransferase Increased: 9 people, 32.14%
  2. Melanocytic Naevus (a type of lesion that contains nevus cells (a type of melanocyte)): 9 people, 32.14%
  3. Seborrhoeic Keratosis (noncancerous (benign) skin growths that some people develop as they age. they often appear on the back or chest): 8 people, 28.57%
  4. Aspartate Aminotransferase Increased: 8 people, 28.57%
  5. Lymphocyte Count Decreased: 7 people, 25.00%
  6. Headache (pain in head): 6 people, 21.43%
  7. High Blood Pressure: 5 people, 17.86%
  8. Fatigue (feeling of tiredness): 5 people, 17.86%
  9. Dermal Cyst: 4 people, 14.29%
  10. Protein Total Increased: 4 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Keratosis pilaris?

- Check whether Keratosis pilaris is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Keratosis pilaris:

All the conditions that are associated with Keratosis pilaris:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Keratosis pilaris and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: